Gå til indhold, Åbn navigation eller Gå til kontaktoplysninger.

Copyright © Inderes 2011 - present. All rights reserved.
Latest
Markeder
Aktieoversigt
Finanskalender
Research
Artikler
InderesTV
Forum
Q&A
Om os
Fulgte selskaber
Team
Indstillinger
Copyright © Inderes 2011 - present. All rights reserved.

Seneste indhold

Viser Alle indholdstyper
Nexstim: Pressure increased on H2
Analyse 21.08.2023 af Antti Siltanen
Nexstim
Modulight: Growth not picking up yet
Analyse 21.08.2023 af Antti Siltanen
Modulight
Nexstim H1 on Friday: Savings sought early in the year
Analytikerkommentar 16.08.2023 af Antti Siltanen
Nexstim
Nexstim announces agreement on growth financing
Analytikerkommentar 11.08.2023 af Antti Siltanen
Nexstim
Modulight: Checking estimates ahead of the Q2 report
Analyse 10.08.2023 af Antti Siltanen
Modulight
Biohit: Positive result from H1 test
Analyse 10.08.2023 af Antti Siltanen
Biohit
Biohit H1 on Wednesday: Looking East
Analytikerkommentar 04.08.2023 af Antti Siltanen
Biohit
Nexstim: Changes in partner’s schedules
Analyse 05.07.2023 af Antti Siltanen
Nexstim
Nightingale reported on its business target achievements for financial year 2022-2023
Analytikerkommentar 04.07.2023 af Frans-Mikael Rostedt, Antti Siltanen
Nightingale Health
Biohit: Preconditions for a turnaround
Video 03.07.2023 af Antti Siltanen, Pia Maljanen
Biohit